Vallourec S.A. (LON:0NR2)
16.09
+0.23 (1.44%)
At close: Oct 31, 2025
Vallourec Revenue
Vallourec had revenue of 863.44M EUR in the quarter ending June 30, 2025, a decrease of -20.40%. This brings the company's revenue in the last twelve months to 3.81B, down -15.12% year-over-year. In the year 2024, Vallourec had annual revenue of 4.03B, down -21.12%.
Revenue (ttm)
3.81B EUR
Revenue Growth
-15.12%
P/S Ratio
1.03
Revenue / Employee
305.16K EUR
Employees
12,497
Market Cap
3.38B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.03B | -1.08B | -21.12% |
| Dec 31, 2023 | 5.11B | 231.02M | 4.73% |
| Dec 31, 2022 | 4.88B | 1.44B | 41.87% |
| Dec 31, 2021 | 3.44B | 199.34M | 6.15% |
| Dec 31, 2020 | 3.24B | -930.65M | -22.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 134.89B |
| Unilever | 51.24B |
| HSBC Holdings | 43.13B |
| AstraZeneca | 41.24B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| British American Tobacco p.l.c. | 25.60B |